Gilteritinib

QR Code

Gilteritinib

Saved in:

Bibliographic Details
Main Authors:	Harini Raghunathan, Parathan Karunakaran
Format:	Article
Language:	English
Published:	Thieme Medical and Scientific Publishers Pvt. Ltd.
Series:	Indian Journal of Medical and Paediatric Oncology
Subjects:	FLT3 mutation relapsed/refractory AML TKI gilteritinib
Online Access:	http://www.thieme-connect.de/DOI/DOI?10.1055/s-0045-1809991
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Recurrent Hyperbilirubinemia with Midostaurin during Consolidation in a Patient of AML with FLT3 Mutation and Review of Literature for Alternative Maintenance Strategy
by: Deepak Kumar Shukla, et al.
Published: (2025-08-01)

LOW DOSE CYTARABINE PLUS SORAFENIB IN AN ELDERLY PATIENT WITH ACUTE MYELOID LEUKEMIA
by: Tural Mahmudov
Published: (2025-07-01)

CAR-T Cell Therapy for Acute Myeloid Leukemia: Where Do We Stand Now?
by: Pilar Lloret-Madrid, et al.
Published: (2025-05-01)

The Novel Diketopiperazine Derivative, Compound 5-3, Selectively Inhibited the Proliferation of FLT3-ITD Mutant Acute Myeloid Leukemia (AML) Cells
by: Shijie Bi, et al.
Published: (2025-07-01)

Sitravatinib combined with venetoclax exerts effective synergy to eliminate acute myeloid leukemia cells with FLT3-ITD mutations
by: Jie Yang, et al.
Published: (2025-09-01)

Targeted therapy of newly diagnosed <i>FLT3</i>-mutated acute myeloid leukemia. A single-center ambispective cohort study
by: N. K. Pastukhov, et al.
Published: (2025-03-01)

Development and preclinical characterization of AMG 329: a human antibody neutralizing FLT3 ligand
by: Annie Lau-Kilby, et al.
Published: (2025-12-01)

Severe congenital neutropenia: pathophysiology of leukemogenic transformation
by: J. Skokowa, et al.
Published: (2022-11-01)

Modern approaches to the treatment of relapsed follicular lymphoma
by: Yu. E. Ryabukhina, et al.
Published: (2022-07-01)

Mosunetuzumab for relapsed or refractory follicular lymphoma: a case study
by: Ya. V. Krylova, et al.
Published: (2024-09-01)

Assessment of the effectiveness of surgical resections following tyrosine kinase inhibitor therapy in patients with EGFR-mutated stage III–IV lung adenocarcinoma
by: E. V. Levchenko, et al.
Published: (2023-02-01)

First‐Line Osimertinib for EGFR‐Mutated Squamous Cell Lung Carcinoma: A Case Report
by: Yugo Matsumura, et al.
Published: (2025-07-01)

Strategies Beyond 3rd EGFR‐TKI Acquired Resistance: Opportunities and Challenges
by: Xuexue Zhou, et al.
Published: (2025-05-01)

Outcome of Pregnancy and Labour in a Patient with Hodgkin’s Lymphoma (Clinical Case)
by: A. A. Borscheva, et al.
Published: (2019-09-01)

Refractory and relapsing forms of <i>Clostridium difficile</i>-associated colitis
by: A. A. Sheptulin
Published: (2011-03-01)

Treatment of pediatric relapsed and refractory acute myeloid leukemia
by: F. A. Makhacheva, et al.
Published: (2023-05-01)

Combination of bendamustine and rituximab in the management of relapsed and refractory chronic lymphocytic leukemia: the results of retrospective study
by: S. V. Semochkin, et al.
Published: (2015-06-01)

Concomitant Use of Analgesics and EGFR TKIs in Lung Cancer Patients: Outcomes and Perspectives From a Finnish Retrospective Register–Based Study
by: Laura S. Puuniemi, et al.
Published: (2025-07-01)

Analysis of TCGA (The Cancer Genome Atlas) Data for Prognosis, Risk Categorization, and Survival of AML Patients Using Bioinformatics
by: Bhavika Rishi, et al.
Published: (2025-08-01)

Combination of hypomethylating agents and inhibitor of BCL-2 in treatment of patients with relapsed acute myeloid leukemia: S.P. Botkin hospital experience
by: M. A. Granatkin, et al.
Published: (2023-03-01)

Efficacy of lenalidomide, bortezomib, and prednisolone in patients with relapsed or refractory multiple myeloma
by: T. A. Мitinа, et al.
Published: (2015-12-01)

FLT3-ITD promotes immune checkpoint CD80 via ROS elevation in acute myeloid leukemia
by: Libo Yan, et al.
Published: (2025-07-01)

Genetic landscape of acute myeloid leukemias with leukocytosis
by: K. A. Pekhova, et al.
Published: (2023-09-01)

Efficacy of IsaPomDex triplet therapy in double refractory multiple myeloma patients in real clinical practice in Russia
by: M. V. Solovev, et al.
Published: (2024-12-01)

The use of immunotherapy for the treatment of refractory forms of Hodgkin lymphoma in real clinical practice.
by: I. A. Kamaeva, et al.
Published: (2021-06-01)

Mutations of the PIK3CA gene in patients with breast cancer in the Krasnoyarsk region
by: A. V. Zyuzyukina, et al.
Published: (2024-07-01)

Recent Advances in the Use of <i>Ganoderma lucidum</i> and <i>Coriolus versicolor</i> Mushrooms to Enhance the Anticancer Efficacy of EGFR-Targeted Drugs in Lung Cancer
by: Hang Zhang, et al.
Published: (2025-07-01)

Combination of Hepatic Arterial Infusion Chemotherapy with Tyrosine Kinase Inhibitor Provides Better Survival in Advanced Hepatocellular Carcinoma Patients
by: Liu CW, et al.
Published: (2025-05-01)

Galectin-3 Release in the Bone Marrow Microenvironment Promotes Drug Resistance and Relapse in Acute Myeloid Leukemia
by: Cansu Yıldırım
Published: (2025-06-01)

Isatuximab in the treatment of refractory and relapsed multiple myeloma: literature review and case report
by: Yu. E. Ryabukhina, et al.
Published: (2023-12-01)

Effectorless Fc-fusion improves FLT3L drug-like properties for cancer immunotherapy combinationsResearch in context
by: Jérémie Decalf, et al.
Published: (2025-08-01)

Long-term endocrine outcomes and quality of life in paediatric and young chronic myeloid leukaemia patients on tyrosine kinase inhibitor therapy: a prospective study from India
by: Rajiv Mohan, et al.
Published: (2025-07-01)

Treatment of relapsed or refractory Hodgkin’s lymphoma with lenalidomide combined with PD-1 monoclonal antibody: a case report and literature review
by: Hongjuan Dong, et al.
Published: (2025-07-01)

Refractory/Relapsed Classic Hodgkin Lymphoma Mimicking Disseminated Tuberculosis
by: Mohamed Nazem Alibrahim, et al.
Published: (2025-05-01)

Elotuzumab in the treatment of patients with refractory and relapsed multiple myeloma Experience of the Lapino Clinical Hospital Oncohematology Department
by: Yu. E. Ryabukhina, et al.
Published: (2023-12-01)

Comparison of fragment analysis and PCR electrophoresis methods for the detection of FLT3‑ITD mutations in patients with acute myeloid leukemia
by: I. E. Maslyukova, et al.
Published: (2022-11-01)

Клинико-гематологическая и молекулярно-генетическая гетерогенность острых миелоидных лейкозов с экспрессией CD7 на бластных клетках
by: С. В. Грицаев, et al.
Published: (2013-10-01)

Clinical Outcome and Molecular Profile in Patients with <i>DDX41</i> Mutation Hot-Spots
by: Nadia Toumeh, et al.
Published: (2025-05-01)

CASE PRESENTATION OF 55-YEAR-OLD MAN WITH ACUTE MYELOID LEUKEMIA AND COVID 19
by: Novita Fajar Sari, et al.
Published: (2022-05-01)

Fasting-mimicking diet enhances EGFR-TKI efficacy in oral cancer through dual mechanisms: direct cancer cell sensitization and tumor-associated macrophage crosstalk
by: Lei Wang, et al.
Published: (2025-07-01)